FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed group of inventions relates to the application of 2,3-dihydroxypropyldodecanoate for treating seborrhoea. Claimed are: application of 2,3-dihydroxypropyldodecanoate for treating seborrhoea, an anti-seborrhoea composition and a method of the cosmetic treatment of seborrhoea.
EFFECT: 2,3-dihydroxypropyldodecanoate inhibited the activity of 5-alpha-reductase, which makes it possible to reduce the metabolism of testosterone into dihydrotestosterone, and, therefore, production of sebum in the treatment of seborrhoea.
12 cl, 1 dwg
Authors
Dates
2015-11-20—Published
2010-12-17—Filed